Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.

An excellent article in this Tuesday’s issue of The New York Times science section tackled that question. “Every day, ...

In Rwanda, cancer remains a leading health challenge, with breast, cervical, and prostate cancers being among the most prevalent. According to Dr. Theoneste Maniragaba, the Director of the Cancer ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...

The speech-language pathology program at Dalhousie University involves three years of full-time study allotted to course work, clinical practica, and a research project or thesis. The program leads to ...

Three independent transfections were performed. Hepatitis C virus core-control (pM -core and pVP16) and ACY3-control (pM and pVP16-ACY3) were included to ensure that HCV core protein and ACY3 ...

Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.